Survival of colorectal cancer patients hospitalized in the veterans affairs health care system

American Journal of Gastroenterology

Volumn 98, Issue 5, 2003, Pages 1186-1192

  Rabeneck, Linda ^a,b   Souchek, Julianne ^a   El Serag, Hashem B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

EID: 0038070368     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07448.x     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures. Atlanta: American Cancer Society, 2001.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Kronberg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
6. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
7. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sig-moidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
8. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
9. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: A case-control study of 32,702 veterans, Ann Intern Med 1995;123:904-10.
10. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
11. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
12. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
13. Rabeneck L, El-Serag HB, Davila JA, Sandler RS. Outcomes of colorectal cancer in the US: No change in survival (1986-1997). Am J Gastroenterol 2003;98:471-77.
14. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 2001;93:501-15.
15. Department of Health and Human Services. The International Classification of Diseases, 9th rev, clinical modification: ICD-9-CM. 3rd ed. Vol 1. Diseases: tabular list. Washington, DC: Government Printing Office, March 1989. DHHS publication no. (PHS) 89-1260.
16. Fisher SG, Weber L, Goldberg J, et al. Mortality ascertainment in the veteran population: Alternatives to the National Death Index. Am J Epidemiol 1995;141:242-50.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
18. FY Veterans Health Survey Research. Available at: http://www.va.gov/NCHP/WhatWeDo, National Center for Health Promotion, 1998.
19. Centers for Disease Control and Prevention. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR 2001;50:162-6.
20. Wingo PA, Ries LA, Parker SL, et al. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev 1998;7:271-82.
21. Dominitz JA, Sarnsa GP, Landsman P, et al. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 1998;82:2312-20.
22. Menke TJ, Rabeneck L, Hartigan PM, et al. Clinical and socioeconomic determinants of health care use among HIV-infected patients in the Department of Veterans Affairs. Inquiry 2000;37:61-74.
23. Gilliland FD, Hunt WC, Key CR. Trends in the survival of American Indian, Hispanic, and non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994. Cancer 1998;82:1769-83.
24. Boyko EJ, Koepsell TD, Gaziano JM, et al. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol 2000;151:307-14.